Brenda Axmann
Obstetrics & Gynecology · Plano, TXNPI 1669421632
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (45.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 64.3% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2023 at $7,069 and has fallen 91.2% since, to $623 in 2025. Among obstetrics & gynecology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 204 payments — averaging $50.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$7K
- AbbVie$487
- Astellas Pharma US Inc$470
- Therapeuticsmd, Inc.$390
- Pfizer$348
- Mayne Pharma Commercial LLC$317
- plus $2K from 25 others
What the payments were for
- Travel & lodging$1,42114%
- Food & beverage$4,21841%
- Education$4,62345%
- Gifts$230%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 13 | $6,612 |
| AbbVie(2 entities) | 33 | $487 |
| Astellas Pharma US Inc | 16 | $470 |
| Therapeuticsmd, Inc. | 23 | $390 |
| Pfizer | 15 | $348 |
| Mayne Pharma Commercial LLC | 18 | $317 |
| Millicent US Inc | 16 | $298 |
| Exeltis, USA Inc. | 13 | $238 |
| Amgen | 7 | $121 |
| Sumitomo Pharma America, Inc. | 4 | $99 |
| Organon | 5 | $99 |
| Myriad Women's Health, Inc. | 1 | $85 |
| Myovant Sciences Inc. | 3 | $77 |
| Duchesnay USA Incorporated | 5 | $63 |
| Merck | 4 | $58 |
| Ascend Therapeutics US, LLC | 4 | $56 |
| Bayer | 2 | $47 |
| Exact Sciences | 3 | $45 |
| Evofem Biosciences, Inc. | 2 | $45 |
| Coopersurgical, Inc. | 1 | $44 |
| Scynexis, Inc. | 2 | $42 |
| AMAG Pharmaceuticals, Inc. | 3 | $38 |
| Vertical Pharmaceuticals, LLC | 2 | $38 |
| Currax Pharmaceuticals LLC | 2 | $32 |
| Aspira Women's Health Inc | 1 | $22 |
| Mycovia Pharmaceuticals, Inc. | 1 | $21 |
| Agile Therapeutics, Inc. | 1 | $20 |
| Meditrina | 1 | $20 |
| Novum Pharma, LLC | 1 | $19 |
| Acella Pharmaceuticals, LLC | 1 | $18 |
| Hologic Sales And Service, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$4,500
- Da Vinci Surgical System$1,940
- Veozah$126
How this compares
$10,285 in reported general payments places this provider in the 90th percentile of 3,099 obstetrics & gynecology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 73 | $11,383 |
| YuvafemEstradiol | 43 | $7,344 |
| Estradiol (Twice Weekly)Estradiol | 57 | $6,617 |
| ImvexxyEstradiol | 19 | $4,122 |
| ProgesteroneProgesterone, Micronized | 80 | $3,204 |
| LyllanaEstradiol | 15 | $2,561 |
| ValacyclovirValacyclovir Hcl | 37 | $987 |
| Ibandronate Sodium | 30 | $710 |
| Levothyroxine Sodium | 26 | $272 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 15 | $153 |
| Fluconazole | 19 | $70 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Therapeuticsmd, Inc.Imvexxy | $390 | $4,12219 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,099 obstetrics & gynecology providers in Texas.
Other obstetrics & gynecology in Plano
- Elizabeth CoronadoPlano$155K
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
- Henry Garza IiiSan Antonio$258K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.